Walday P, Fyllingen E, Aas P
Norwegian Defence Research Establishment, Division for Environmental Toxicology, Kjeller.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Sep;346(3):352-7. doi: 10.1007/BF00173551.
The effect of the calcium antagonists omega-conotoxin GVIA, verapamil, gallopamil and diltiazem was investigated on in vitro bronchial smooth muscle contraction in the rat induced by the nerve agent soman. Soman inhibits the acetylcholinesterase activity irreversibly. The effect of the calcium channel antagonists on contractions induced by electrical field stimulation and carbachol was also investigated, in order to elucidate the mechanism by which calcium antagonists inhibit the soman induced contraction. omega-Conotoxin GVIA reduced the bronchial smooth muscle contraction induced by electrical field stimulation with an almost complete inhibition at approximately 1.0 x 10(-6) M. The soman induced contraction was only inhibited by 15% at a concentration of 3.0 x 10(-6) M omega-conotoxin GVIA. The organic calcium antagonists verapamil, gallopamil and diltiazem reduced both electrically and soman induced smooth muscle contraction. Complete inhibition of the contractions induced by soman was achieved at 1.4 x 10(-4) M for verapamil and gallopamil, while diltiazem inhibited the contraction to 7% of control at 1.4 x 10(-4) M. Verapamil, gallopamil and diltiazem increased the EC50 for carbachol significantly, while omega-conotoxin GVIA had no effect. None of the calcium antagonists had any effect on the maximal contraction induced by carbachol. Verapamil, gallopamil and diltiazem blocked, however, sub-maximal contractions induced by carbachol (10(-7)-10(-5) M) resulting in a right-shift of the dose response curve. The results show that omega-conotoxin GVIA inhibits the calcium-dependent release of acetylcholine which causes contraction of airway smooth muscle, while it has no effect on smooth muscle contraction induced by soman.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了钙拮抗剂ω-芋螺毒素GVIA、维拉帕米、加洛帕米和地尔硫䓬对大鼠体内由神经毒剂梭曼诱导的体外支气管平滑肌收缩的影响。梭曼不可逆地抑制乙酰胆碱酯酶活性。还研究了钙通道拮抗剂对电场刺激和卡巴胆碱诱导的收缩的影响,以阐明钙拮抗剂抑制梭曼诱导收缩的机制。ω-芋螺毒素GVIA降低了电场刺激诱导的支气管平滑肌收缩,在约1.0×10⁻⁶ M时几乎完全抑制。在3.0×10⁻⁶ M的ω-芋螺毒素GVIA浓度下,梭曼诱导的收缩仅被抑制15%。有机钙拮抗剂维拉帕米、加洛帕米和地尔硫䓬降低了电刺激和梭曼诱导的平滑肌收缩。维拉帕米和加洛帕米在1.4×10⁻⁴ M时完全抑制了梭曼诱导的收缩,而地尔硫䓬在1.4×10⁻⁴ M时将收缩抑制至对照的7%。维拉帕米、加洛帕米和地尔硫䓬显著增加了卡巴胆碱的半数有效浓度(EC50),而ω-芋螺毒素GVIA没有影响。钙拮抗剂均对卡巴胆碱诱导的最大收缩没有任何影响。然而,维拉帕米、加洛帕米和地尔硫䓬阻断了卡巴胆碱(10⁻⁷ - 10⁻⁵ M)诱导的次最大收缩,导致剂量反应曲线右移。结果表明,ω-芋螺毒素GVIA抑制引起气道平滑肌收缩的乙酰胆碱的钙依赖性释放,而对梭曼诱导的平滑肌收缩没有影响。(摘要截短至250字)